Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

News > All

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 2606 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. 2019-10-16
Gilead Sciences, Inc.. (10/15/19). "Press Release: Gilead Sciences Appoints Andrew Dickinson as Chief Financial Officer". Foster City, CA. 2019-10-15
UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA. 2019-10-10
N-Side S.A.. (10/9/19). "Press Release: N-Side Welcomes Wade Wirta as US Managing Director". Louvain-la-Neuve. 2019-10-09
Bluebee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk. 2019-10-09
Illumina, Inc.. (10/7/19). "Press Release: Illumina and Qiagen Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests". San Diego, CA & Hilden & Germantown, MD. 2019-10-07
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Announces CEO Leadership Transition. Peer M. Schatz to Step Down as CEO to Pursue New Opportunities". Venlo. 2019-10-07
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation". Venlo. 2019-10-07
Univercells S.A.. (10/3/19). "Press Release: Univercells Boosted by EUR 20m European Financing to Accelerate the Delivery of Its Vaccine Portfolio". Brussels. 2019-10-03
Immunexpress, Inc.. (10/3/19). "Press Release: Immunexpress Announces Closing of Private Funding Round". Seattle, WA. 2019-10-03
Cellectis S.A.. (10/1/19). "Press Release: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates". Basel & New York, NY. 2019-10-01
N-Side S.A.. (10/1/19). "Press Release: AstraZeneca Selects N-Side Suite for Clinical Trials to Optimize and Monitor Clinical Trial Supply Chain". Louvain-la-Neuve. 2019-10-01
BASF SE. (9/27/19). "Press Release: BASF’s Strategy in Agriculture Aims for Innovation-driven Growth in Specific Markets". 2019-09-27
Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services". 2019-09-20
Menarini Silicon Biosystems S.p.A.. (9/19/19). "Press Release: Menarini Silicon Biosystems Launches the MSBiosuite Bioinformatic Platform, Partners with BlueBee". Bologna. 2019-09-19
Novigenix S.A.. (9/19/19). "Press Release: Novigenix and BioLizard Sign Collaboration Agreement for Development of NGS Based Diagnostic Algorithm". Lausanne. 2019-09-19
Versantis AG. (9/18/19). "Press Release: Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases". Zürich. 2019-09-18
ESMO. (9/18/19). "Press Release: Electronic Nose Can Sniff Out Which Lung Cancer Patients Will Respond to Immunotherapy [Annals of Oncology Press Release]". 2019-09-18
Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. 2019-09-16
Immunexpress, Inc.. (9/11/19). "Press Release: Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations". Seattle, WA. 2019-09-11
Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam. 2019-09-10
Pharvaris B.V.. (9/10/19). "Press Release: Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema". Leiden. 2019-09-10
Uniqure N.V.. (9/5/19). "Press Release: Uniqure Announces Pricing of its Public Offering". Lexington, MA & Amsterdam. 2019-09-05
iStar Medical S.A.. (9/5/19). "Press Release: iStar Medical Announces EUR 40m Series C Financing". Wavre. 2019-09-05
Uniqure N.V.. (9/4/19). "Press Release: Uniqure Announces Proposed Public Offering". Lexington, MA & Amsterdam. 2019-09-04
Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. 2019-09-04
Uniqure N.V.. (9/3/19). "Press Release: Uniqure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-09-03
Achilles Therapeutics. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. 2019-09-03
Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf. 2019-08-29
Galapagos N.V.. (8/28/19). "Press Release: Transparency Notification – Gilead Holds 22% of Galapagos Shares". Mechelen. 2019-08-28
Galapagos N.V.. (8/23/19). "Press Release: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration". Foster City, CA & Mechelen. 2019-08-23
Uniqure N.V.. (8/20/19). "Press Release: Uniqure Announces Leadership Promotions and Executive Transition". Lexington, MA & Amsterdam. 2019-08-20
Galapagos N.V.. (8/15/19). "Press Release: European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis". Foster City, CA & Mechelen. 2019-08-15
Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden. 2019-08-13
iTeos Therapeutics S.A.. (8/13/19). "Press Release: iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer". Gosselies & Cambridge, MA. 2019-08-13
Curetis N.V.. (8/12/19). "Press Release: Curetis Retains H.C. Wainwright & Co. as Strategic Advisor". Amsterdam & Holzgerlingen. 2019-08-12
Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. 2019-08-08
Eurofins Genomics LLC. (8/6/19). "Press Release: Eurofins Genomics US Expands Gene Synthesis Capabilities with Acquisition of Blue Heron Biotech". Louisville, KY. 2019-08-06
Platomics GmbH. (8/6/19). "Press Release: 7-digit Investment in Future Technology Genetic Testing". 2019-08-06
Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London. 2019-08-05
Imcyse. (8/5/19). "Press Release: Imcyse Announces Changes in Management and Board, Appoints Thomas Taapken as Executive Chairman". Liège. 2019-08-05
Curetis N.V.. (8/1/19). "Press Release: Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes". Amsterdam, San Diego, CA & Holzgerlingen. 2019-08-01
AgroSavfe N.V.. (7/30/19). "Press Release: AgroSavfe Raises €35 million in Series C Financing". Ghent. 2019-07-30
Curetis N.V.. (7/30/19). "Press Release: Curetis and Ako Med Ink Distribution Agreement Covering Four Countries in CEE Region". Amsterdam, San Diego, CA & Holzgerlingen. 2019-07-30
Bluebee. (7/25/19). "Press Release: As BlueBee Expands Commercial Operations in the US, Pam Cheng Joins the BlueBee Management Team to Lead Product Strategy". San Mateo, CA. 2019-07-25
Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. 2019-07-25
Qiagen N.V.. (7/24/19). "Press Release: Qiagen Reports Results for Second Quarter of 2019 – Updates Full-year 2019 Outlook Due to Decision to Restructure China NGS Partnership". Venlo. 2019-07-24
Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. 2019-07-19
AM-Pharma B.V.. (7/16/19). "Press Release: AM-Pharma Raises €116m ($133m) to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury". Bunnik. 2019-07-16
Evotec SE. (7/15/19). "Press Release: Evotec Expands Its iPSC Platform. Acquired Assets from Ncardia AG". Hamburg. 2019-07-15
Galapagos N.V.. (7/14/19). "Press Release: Gilead and Galapagos Enter into Transformative Research and Development Collaboration". Foster City, CA & Mechelen. 2019-07-14
SMS-Oncology (Specialized Medical Services-Oncology B.V.). (7/8/19). "Press Release: SMS-Oncology Opens New Office in Frankfurt, Germany". Schiphol. 2019-07-08
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
Confo Therapeutics N.V.. (7/3/19). "Press Release: Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-modulating Compounds". Ghent & Dresden. 2019-07-03
Citryll B.V.. (7/3/19). "Press Release: Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody". Oss. 2019-07-03
AgroSavfe N.V.. (7/2/19). "Press Release: AgroSavfe Appoints Patrice Sellès as New Chief Executive Officer and further Strengthens Leadership Team". Ghent. 2019-07-02
[iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. 2019-07-01
Curetis N.V.. (6/28/19). "Press Release: Curetis Reports Results of the Annual General Meeting Held on June 27, 2019. All Proposed AGM Resolutions Approved by Shareholders". Amsterdam, San Diego, CA & Holzgerlingen. 2019-06-28
CryoTherapeutics GmbH / CryoTherapeutics S.A.. (6/27/19). "Press Release: CryoTherapeutics Closes Series B Financing Round at EUR 7 Million". Awans & Cologne. 2019-06-27
ImmunoPrecise Antibodies Ltd.. (6/26/19). "Press Release: ImmunoPrecise Guarantees Success for Customers of Their Well-established B Cell Select Antibody Discovery Platform". Victoria, BC. 2019-06-26
Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. 2019-06-26
Eurofins Scientific. (6/25/19). "Press Release: Eurofins Expands Its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.". Luxembourg. 2019-06-25
Vesalius Biocapital Partners Sàrl. (6/25/19). "Press Release: Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund". Strassen, Luxembourg. 2019-06-25
Eurofins Scientific. (6/24/19). "Press Release: Operations Returning to Normal After the Cyber Attack Announced on June 3, 2019". Luxembourg. 2019-06-24
Oxford Immunotec Global plc. (6/24/19). "Press Release: Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman". Oxford & Marlborough, MA. 2019-06-24
Lonza Group Ltd.. (6/19/19). "Press Release: Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel". Basel & Boston, MA. 2019-06-19
Imcyse. (6/18/19). "Press Release: Imcyse Secures Total of €35M in Series B Financing Round and Additional Grants". Liège. 2019-06-18
Probiodrug AG. (6/12/19). "Press Release: Probiodrug AG Becomes Vivoryon Therapeutics AG". Halle (Saale). 2019-06-12
Kiadis Pharma N.V.. (6/6/19). "Press Release: Kiadis Pharma Completes Acquisition of CytoSen Therapeutics, Inc.". Amsterdam. 2019-06-06
InflaRx N.V.. (6/5/19). "Press Release: InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa". Jena. 2019-06-05
Qiagen N.V.. (6/5/19). "Press Release: Qiagen and DiaSorin Collaborate on Novel QuantiFERON-based Test with Breakthrough Potential for Earlier Detection of Lyme Disease". Germantown, MD, Hilden & Saluggia. 2019-06-05
Curetis N.V.. (6/4/19). "Press Release: New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019". Amsterdam, San Diego, CA & Holzgerlingen. 2019-06-04
Biocartis Group N.V.. (6/1/19). "Press Release: Biocartis and Kite Sign Agreement for Development of Assays Supporting Kite's Therapies". Mechelen. 2019-06-01
Kiadis Pharma N.V.. (5/31/19). "Press Release: Kiadis Pharma Raises c.EUR 28 Million in a Private Placement of c.3.7 Million New Shares [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam. 2019-05-31
[iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme 2019-05-30
Kiadis Pharma N.V.. (5/30/19). "Press Release: Kiadis Pharma Launches a Private Placement of New Shares to Raise approximately EUR 25 Million [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam. 2019-05-30
Kiadis Pharma N.V.. (5/29/19). "Press Release: Kiadis Pharma’s Extraordinary General Meeting of Shareholders Approves CytoSen Acquisition". Amsterdam. 2019-05-29
Galapagos N.V.. (5/29/19). "Press Release: Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)". Foster City, CA & Mechelen. 2019-05-29
Affimed N.V.. (5/22/19). "Press Release: Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio, Reports First Quarter 2019 Financial Results and Operational Progress". Heidelberg. 2019-05-22
Kiadis Pharma N.V.. (5/22/19). "Press Release: Be The Match BioTherapies and Kiadis Pharma Announce Strategic Collaboration to Accelerate Patient Access to Haploidentical Stem Cell Therapies". Minneapolis, MN & Amsterdam. 2019-05-22
Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield. 2019-05-20
Storm Therapeutics Ltd.. (5/20/19). "Press Release: Storm Therapeutics Extends Series A to GBP 30M (USD 38.43M) with Wew Investor, Seroba Life Sciences". Cambridge. 2019-05-20
Bluebird Bio, Inc.. (5/16/19). "Press Release: Bluebird Bio to Present New Data from Clinical Studies of LentiGlobin Gene Therapy for Transfusion-Dependent ß-thalassemia (TDT) and LentiGlobin Gene Therapy for Sickle Cell Disease (SCD) at the 24th EHA Con 2019-05-16
DNA Script. (5/16/19). "Press Release: DNA Script Raises $38.5 Million in Series B Financing. Oversubscribed Round Led by LSP". Paris. 2019-05-16
Qiagen N.V.. (5/16/19). "Press Release: Qiagen and Inovio Collaborate to Develop Companion Diagnostic for Novel Immunotherapy Targeting Precancerous Cervical Lesions". Hilden, Germantown, MD & Plymouth Meeting, PA. 2019-05-16
Mobidiag Oy. (5/14/19). "Press Release: Investment Plan for Europe – Mobidiag Secures EUR 25 million from EIB". 2019-05-14
Icometrix. (5/14/19). "Press Release: Brain Imaging AI Leader Icometrix Raises $18 Million in New Funding". Leuven, Geenva & Boston, MA. 2019-05-14
Uniqure N.V.. (5/10/19). "Press Release: Uniqure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-05-10
Qiagen N.V.. (5/10/19). "Press Release: Disclosure According to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase". 2019-05-10
Promethera Biosciences S.A.. (5/7/19). "Press Release: Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing". Mont-Saint-Guibert & Tokyo. 2019-05-07
Confo Therapeutics N.V.. (5/7/19). "Press Release: Confo Therapeutics Raises €30 Million in Series A Financing". Ghent. 2019-05-07
MorphoSys AG. (5/7/19). "Press Release: MorphoSys AG Reports First Quarter 2019 Results". Planegg. 2019-05-07
Enzyre B.V.. (4/30/19). "Press Release: Enzyre Appoints Dirk Pollet as Chief Executive Officer. Awarded €2M Grant and Completes Seed Financing". Nijmegen. 2019-04-30
SGS S.A.. (4/30/19). "Press Release: SGS Implements Veeva Vault Clinical Trial Management System across its Global Network". 2019-04-30
Uniqure N.V.. (4/29/19). "Press Release: Uniqure Announces First Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2019-04-29
Iktos. (4/29/19). "Press Release: Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery". Paris. 2019-04-29
Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. 2019-04-27
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Reaches New Milestone – Now more than 9,900 European Life Science Deals Available at Life-Sciences-Europe.com". Bremen. 2019-04-26
Galapagos N.V.. (4/25/19). "Press Release: Galapagos Reports on Historic First Quarter 2019". Mechelen. 2019-04-25
Biocartis Group N.V.. (4/25/19). "Press Release: Biocartis Q1 2019 Business Update". Mechelen. 2019-04-25
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top